Discover why Johnson & Johnson is a top stock pick for income investors in 2025 with strong sales growth and promising earnings outlook.

Welcome to The Hill’s Business & Economy newsletter {beacon} Business & Economy Business & Economy The Big Story  Trump warns ...

GOP lawmakers were caught off guard by the president’s remarks Thursday about the deadly collision …{beacon} Evening Report ...

Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It is designed for easy ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...

Republicans face a series of tough choices on the price tag and spending cuts in the months ahead.

Shares of Netflix soared after the company posted fourth-quarter results that beat on the top and bottom lines.

After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations.